Germany argued that Evergreen had negotiated with other possible joint venture partners on the basis of a participation exceeding 75 %, but failed to submit evidence in writing of such negotiations. Germany offered in some correspondence to provide declarations under oath by representatives of Evergreen and Q-Cells on the considerations behind the 24,9 % share, but did finally not submit them.
99 6. ASSESSMENT OF THE AID › 6.3. Assessment of SME status of Sovello › 6.3.3. Company documents and factual situation, Decision_act (EU) 2010/358
In forcesince 27 Jan 2010